Itraconazole (Itrazole) cap 100 mg: Supply issue resolved

Affected product

Viatris, the supplier, advised that there was an issue at one of its manufacturing plants which has delayed a delivery of itraconazole 100 mg capsules. 

Itraconazole

• Brand: Itrazole
• Presentation: Cap 100 mg
• Pharmacode: 2354322
• Subsidy: $6.83
• Measure / Qty: per 15

Note there is also a brand change for the itraconazole oral liquid

Alternative product

Itraconazole Crescent (listed 1 May 2025)

To ensure people can continue to access treatment, we listed a second alternative brand of itraconazole. It is a 15 pack (like the Itrazole) 

• Brand: Itraconazole Cresent 
• Pharmacode: 2705109 
• Subsidy: $6.83
• Measure / Qty: per 15

This product is also not Medsafe-registered and will need to be prescribed and dispensed in line with the Medicines Act.

Itracap alternative (listed 1 February 2025)

Viatris will be providing its "Itracap" brand of itraconazole until Itrazole is available again. This product will be listed from 1 February 2025. It is also supplied as a 60 pack (while the currently listed product comes in a 15 pack). 

• Brand: Itracap
• Presentation: Cap 100 mg
• Pharmacode: 2698560
• Subsidy: $27.32
• Measure / Qty: per 60

This product is made by Viatris, but is not Medsafe-registered. It will have to be prescribed and dispensed in line with section 29 of the Medicines Act.

We have prepared a flier to support pharmacists' conversations with affected people.

Prescribing and supplying an unapproved medicine

Section 29 of the Medicines Act 1981 allows for medicines that are not Medsafe approved to be prescribed and supplied to people. The medicine must be prescribed by someone registered with the Medical Council of New Zealand – such as, a doctor. 

We know supplying a medicine under section 29 is not ideal. In this case, however, this will allow patients to be able to access an appropriate treatment. 

We apologise for any inconvenience this causes. 

Advice for prescribing under section 29 – BPAC website(external link) 

Prescriber and pharmacist requirements for section 29 medicines – Medsafe website(external link)

Medsafe’s section 29 Declaration / Notification Form [DOC](external link)

What patients need to know about unapproved medicines – Healthify website(external link)

Resupplied May 2025

As at 21 May 2025, stock has arrived and been released to wholesalers. It can take another 1 to 2 weeks to reach pharmacies around the motu.

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.

Sign up to our email list for regular emails about supply issues and more(external link)